Search research articles
Contact Us
Filters
Showing results (111-120 of 230) with videos related to
Page
of 23
Sort By:
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
November 20, 2020
Influence of tumor necrosis on treatment sensitivity and long-term survival in nasopharyngeal carcinoma
Shao-Bo Liang, Lu-Si Chen, Xing-Li Yang, et al.
EMBO Reports
|
July 18, 2025
Transcriptome-wide decoding the roles of aberrant splicing in melanoma MAPK-targeted resistance evolution
Jing Yu, Xiujing He, Xueyan Wang, et al.
Frontiers in Immunology
|
July 22, 2021
Association of NRAS Mutation With Clinical Outcomes of Anti-PD-1 Monotherapy in Advanced Melanoma: A Pooled Analysis of Four Asian Clinical Trials
Li Zhou, Xuan Wang, Zhihong Chi, et al.
Cancer Science
|
March 25, 2025
CNDP1 Overexpression by Promoter Hypomethylation Predicts Poor Prognosis and Immunotherapy Response in Mucosal Melanoma
Jia Jia, Junjie Gu, Lina Gao, et al.
Cancer Biology & Therapy
|
May 1, 2018
PI3K/AKT/mTOR pathway inhibitors inhibit the growth of melanoma cells with mTOR H2189Y mutations in vitro
Xiaowen Wu, Jiayi Yu, Junya Yan, et al.
Melanoma Research
|
February 22, 2022
Phase II study of apatinib combined with temozolomide in patients with advanced melanoma after failure of immunotherapy
Li Zhou, Yue Yang, Lu Si, et al.
Journal of Cancer Research and Clinical Oncology
|
February 21, 2021
Real-world analysis of clinicopathological characteristics, survival rates, and prognostic factors in patients with melanoma brain metastases in China
Yang Wang, Bin Lian, Lu Si, et al.
Translational Oncology
|
November 22, 2020
Chemotherapy combined with antiangiogenic drugs as salvage therapy in advanced melanoma patients progressing on PD-1 immunotherapy
Xuan Wang, Weiran Xu, Zhihong Chi, et al.
Frontiers of Medicine
|
May 14, 2024
Assessment of HER2 status in extramammary Paget disease and its implication for disitamab vedotin, a novel humanized anti-HER2 antibody-drug conjugate therapy
Jia Jia, Lili Mao, Jing Lin, et al.
Oncology Letters
|
September 21, 2017
Mutations in BRAF codons 594 and 596 predict good prognosis in melanoma
Xiaowen Wu, Junya Yan, Jie Dai, et al.
Page
of 23
Search research articles
Search
Showing results (111-120 of 230) with videos related to
Sort By:
Page
of 23
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
November 20, 2020
Influence of tumor necrosis on treatment sensitivity and long-term survival in nasopharyngeal carcinoma
Shao-Bo Liang, Lu-Si Chen, Xing-Li Yang, et al.
EMBO Reports
|
July 18, 2025
Transcriptome-wide decoding the roles of aberrant splicing in melanoma MAPK-targeted resistance evolution
Jing Yu, Xiujing He, Xueyan Wang, et al.
Frontiers in Immunology
|
July 22, 2021
Association of NRAS Mutation With Clinical Outcomes of Anti-PD-1 Monotherapy in Advanced Melanoma: A Pooled Analysis of Four Asian Clinical Trials
Li Zhou, Xuan Wang, Zhihong Chi, et al.
Cancer Science
|
March 25, 2025
CNDP1 Overexpression by Promoter Hypomethylation Predicts Poor Prognosis and Immunotherapy Response in Mucosal Melanoma
Jia Jia, Junjie Gu, Lina Gao, et al.
Cancer Biology & Therapy
|
May 1, 2018
PI3K/AKT/mTOR pathway inhibitors inhibit the growth of melanoma cells with mTOR H2189Y mutations in vitro
Xiaowen Wu, Jiayi Yu, Junya Yan, et al.
Melanoma Research
|
February 22, 2022
Phase II study of apatinib combined with temozolomide in patients with advanced melanoma after failure of immunotherapy
Li Zhou, Yue Yang, Lu Si, et al.
Journal of Cancer Research and Clinical Oncology
|
February 21, 2021
Real-world analysis of clinicopathological characteristics, survival rates, and prognostic factors in patients with melanoma brain metastases in China
Yang Wang, Bin Lian, Lu Si, et al.
Translational Oncology
|
November 22, 2020
Chemotherapy combined with antiangiogenic drugs as salvage therapy in advanced melanoma patients progressing on PD-1 immunotherapy
Xuan Wang, Weiran Xu, Zhihong Chi, et al.
Frontiers of Medicine
|
May 14, 2024
Assessment of HER2 status in extramammary Paget disease and its implication for disitamab vedotin, a novel humanized anti-HER2 antibody-drug conjugate therapy
Jia Jia, Lili Mao, Jing Lin, et al.
Oncology Letters
|
September 21, 2017
Mutations in BRAF codons 594 and 596 predict good prognosis in melanoma
Xiaowen Wu, Junya Yan, Jie Dai, et al.
Page
of 23